Morepen Laboratories Ltd

NSE: MOREPENLAB · BSE: 500288 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹148.38
Market cap: ₹8,131 Cr
Revenue (annual): ₹1,806 Cr
Net profit (annual): ₹94.88 Cr
P/E (TTM): 57.9×Sector 47.4×
Promoter holding: 35.65%+0.00% QoQ
FII holding: 1.46%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

1 Jul 2026 08:44 IST NSE

Morepen Laboratories Business Update

Morepen Laboratories started commercial supplies under an ₹825 Crore CDMO mandate. The first dispatch of ₹50 Crore was completed in Q1FY2026-27.

Value: ₹825.0 Cr

Read the filing ↗

26 May 2026 18:12 IST NSE

Business Update

Morepen Laboratories Business Update

Morepen Laboratories revised the 'Appointed Date' for its internal business transfer to subsidiary Morepen Medipath to April 1, 2026. The delay allows time for statutory and regulatory approvals.

Read the filing ↗